← All companies

ASND

Ascendis Pharma A/S

ASND Nasdaq Pharmaceutical Preparations EDGAR ↗

$243.45

-7.62 -3.04%

Key statistics

from XBRL data in SEC filings

Market cap

$15.1B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$173.33 – $282.15

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 15, 2026 6-K Jun 30, 2026 6-K Jun 29, 2026 6-K Jun 17, 2026 6-K Jun 15, 2026 6-K Jun 12, 2026 6-K Jun 10, 2026 6-K May 13, 2026 6-K May 7, 2026 6-K May 7, 2026 6-K Apr 21, 2026 6-K Apr 21, 2026 6-K Apr 20, 2026 6-K Apr 16, 2026 6-K Apr 8, 2026 6-K Apr 8, 2026 6-K Apr 7, 2026 6-K Mar 30, 2026 6-K Mar 24, 2026 6-K Mar 17, 2026 6-K Mar 16, 2026 6-K Mar 11, 2026 6-K Mar 2, 2026 6-K Feb 23, 2026 6-K Feb 11, 2026 20-F Feb 11, 2026 6-K Feb 11, 2026 6-K Jan 14, 2026 6-K Jan 12, 2026 6-K Jan 9, 2026 6-K Dec 30, 2025 6-K Dec 10, 2025 6-K Nov 26, 2025 6-K Nov 12, 2025 6-K Nov 12, 2025 6-K Nov 12, 2025 6-K Oct 22, 2025 6-K Oct 15, 2025 6-K Oct 8, 2025 6-K Sep 30, 2025